血清素综合征
医学
5-羟色胺能
齐拉西酮
血清素
曲马多
三环
药理学
丘脑底核
再摄取抑制剂
MDMA公司
5-羟色胺再摄取抑制剂
血清素激动剂
脑深部刺激
抗精神病药
麻醉
精神科
疾病
帕金森病
内科学
精神分裂症(面向对象编程)
止痛药
受体
作者
Nasser El-Okdi,Daniel Lumbrezer,Djuro Karanovic,Abhimanyu Ghose,Ragheb Assaly
标识
DOI:10.1097/mjt.0b013e3182456d88
摘要
Serotonin syndrome (SS) is a life-threatening adverse reaction that can result from the therapeutic use of serotonergic drugs or accidental drug interactions. Tramadol is a drug that is widely prescribed because of its low abuse potential, but physicians need to be aware of its significant potential to cause SS because it inhibits serotonin reuptake. Ziprasidone is an atypical antipsychotic that can also cause dangerous interactions to cause SS because it is not only a potent 5-HT1A agonist but also has been reported to inhibit serotonin reuptake with an affinity similar to tricyclic antidepressants, in addition to inhibiting reuptake of norepinephrine. We are describing the clinical characteristics of a gentleman with bipolar disorder and Parkinson disease who presented with SS, despite having a deep brain stimulator in the subthalamic nucleus, which decreases central serotonin levels, and a discussion of the factors that contributed to his presentation.
科研通智能强力驱动
Strongly Powered by AbleSci AI